Compare SRPT & FULTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRPT | FULTP |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | United States |
| Employees | N/A | 3400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | N/A |
| IPO Year | 1997 | N/A |
| Metric | SRPT | FULTP |
|---|---|---|
| Price | $21.70 | $19.18 |
| Analyst Decision | Hold | |
| Analyst Count | 29 | 0 |
| Target Price | ★ $26.23 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | N/A |
| Earning Date | 11-03-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,413,715,000.00 | N/A |
| Revenue This Year | $13.72 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.15 | N/A |
| 52 Week Low | $10.42 | N/A |
| 52 Week High | $129.84 | N/A |
| Indicator | SRPT | FULTP |
|---|---|---|
| Relative Strength Index (RSI) | 53.31 | 43.63 |
| Support Level | $20.14 | $19.06 |
| Resistance Level | $22.52 | $19.33 |
| Average True Range (ATR) | 1.04 | 0.20 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 54.10 | 34.62 |
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.